{"DataElement":{"publicId":"4976031","version":"1","preferredName":"Imaging Technique Disease Response National Cancer Institute Reviewer Evaluation Tumor Response Type","preferredDefinition":"The coded response indicating the disease response as determined by NCI Reviewers based on imaging scans.","longName":"IMG_DZ_RESP_NCI_TYP","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"4971257","version":"1","preferredName":"Imaging Technique Disease Response National Cancer Institute Reviewer Evaluation","preferredDefinition":"Any technology or method that aids in the visualization of any biological process, cell, tissue or organ for use in screening, diagnosis, surgical procedures or therapy._The pathologic and/or clinical changes that result from treatment. The changes may include eradication of detectable disease, stabilization of disease, or disease progression._The National Cancer Institute, part of the National Institutes of Health of the United States Department of Health and Human Services, is the Federal Government's principal agency for cancer research. The National Cancer Institute conducts, coordinates, and funds cancer research, training, health information dissemination, and other programs with respect to the cause, diagnosis, prevention, and treatment of cancer. Access the National Cancer Institute Web site at http://www.cancer.gov._A person with a responsibility for examining something to make sure that it is adequate, accurate, or correct._Systematic, objective appraisal of the significance, effectiveness, and impact of activities or condition according to specified objectives and criteria.","longName":"4971271v1.0:4971272v1.0","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"4971271","version":"1","preferredName":"Imaging Technique Disease Response","preferredDefinition":"Any technology or method that aids in the visualization of any biological process, cell, tissue or organ for use in screening, diagnosis, surgical procedures or therapy.:The pathologic and/or clinical changes that result from treatment. The changes may include eradication of detectable disease, stabilization of disease, or disease progression.","longName":"C17369:C50995","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Imaging Technique","conceptCode":"C17369","definition":"Any technology or method that aids in the visualization of any biological process, cell, tissue or organ for use in screening, diagnosis, surgical procedures or therapy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Disease Response","conceptCode":"C50995","definition":"The pathologic and/or clinical changes that result from treatment. The changes may include eradication of detectable disease, stabilization of disease, or disease progression.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1D4E9164-82AB-BC25-E050-BB89AD43743D","latestVersionIndicator":"Yes","beginDate":"2015-08-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-08-14","modifiedBy":"ONEDATA","dateModified":"2015-08-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"4971272","version":"1","preferredName":"National Cancer Institute Reviewer Evaluation","preferredDefinition":"The National Cancer Institute, part of the National Institutes of Health of the United States Department of Health and Human Services, is the Federal Government's principal agency for cancer research. The National Cancer Institute conducts, coordinates, and funds cancer research, training, health information dissemination, and other programs with respect to the cause, diagnosis, prevention, and treatment of cancer. Access the National Cancer Institute Web site at http://www.cancer.gov.:A person with a responsibility for examining something to make sure that it is adequate, accurate, or correct.:Systematic, objective appraisal of the significance, effectiveness, and impact of activities or condition according to specified objectives and criteria.","longName":"C19202:C54634:C25214","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"National Cancer Institute","conceptCode":"C19202","definition":"The Federal Government's principal agency for cancer research. NCI conducts, coordinates, and funds cancer research, training, health information dissemination, and other programs with respect to the cause, diagnosis, prevention, and treatment of cancer. Part of the National Institutes of Health of the United States Department of Health and Human Services.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Reviewer","conceptCode":"C54634","definition":"A person with a responsibility for examining something to make sure that it is adequate, accurate, or correct.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Evaluation","conceptCode":"C25214","definition":"Systematic, objective appraisal of the significance, effectiveness, and impact of activities or condition according to specified objectives and criteria.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1D4E9164-82BD-BC25-E050-BB89AD43743D","latestVersionIndicator":"Yes","beginDate":"2015-08-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-08-14","modifiedBy":"ONEDATA","dateModified":"2015-08-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008550","version":"1","preferredName":"Disease Response","preferredDefinition":"the response criteria (includes RECIST and others) and associated documentation of disease.","longName":"DZ_RESP","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22C0651-216B-5273-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CTEP:Cancer Therapy Evaluation Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1D4E9164-828F-BC25-E050-BB89AD43743D","latestVersionIndicator":"Yes","beginDate":"2015-08-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-08-14","modifiedBy":"CAMPBELB","dateModified":"2017-10-04","changeDescription":"Cleanup; ER_CTEP_08.14.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2015153","version":"5","preferredName":"Tumor Response Type","preferredDefinition":"an enumerated list of tumor/disease responses.","longName":"TUMOR_RESP_TP","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":"1","maxLength":"80","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"CR","valueDescription":"Complete Response","ValueMeaning":{"publicId":"2570187","version":"1","preferredName":"Complete Response","longName":"2570187","preferredDefinition":"The disappearance of all signs of cancer in response to treatment.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Complete Remission","conceptCode":"C4870","definition":"The disappearance of all signs of cancer in response to treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-DF38-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-06-21","endDate":null,"createdBy":"SBR","dateCreated":"2004-06-21","modifiedBy":"KUMMEROA","dateModified":"2023-09-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E0258697-04CF-5468-E034-0003BA12F5E7","beginDate":"2002-07-10","endDate":null,"createdBy":"PWEST","dateCreated":"2004-07-26","modifiedBy":"SBREXT","dateModified":"2007-06-22","deletedIndicator":"No"},{"value":"Early death","valueDescription":"DEATH PRIOR TO COMPLETION OF PROTOCOL CRITERIA","ValueMeaning":{"publicId":"2558599","version":"1","preferredName":"DEATH PRIOR TO COMPLETION OF PROTOCOL CRITERIA","longName":"2558599v1.00","preferredDefinition":"Earlier in time or order._To possess every necessary or normal part or component or step; having come or been brought to a conclusion._A rule which guides how an activity should be performed._That which constitutes a standard from which a judgment can be established, a reference point against which other things can be evaluated, or a basis for comparison._The cessation of life.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prior","conceptCode":"C25629","definition":"Earlier in time or order.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Complete","conceptCode":"C25250","definition":"To possess every necessary or normal part or component or step; having come or been brought to a conclusion.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Protocol","conceptCode":"C42651","definition":"A rule which guides how an activity should be performed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Criterion","conceptCode":"C25466","definition":"That which constitutes a standard from which a judgment can be established, a reference point against which other things can be evaluated, or a basis for comparison.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Dead","conceptCode":"C28554","definition":"The cessation of life.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B1F4-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"KUMMEROA","dateModified":"2023-09-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E0258697-04D1-5468-E034-0003BA12F5E7","beginDate":"2002-02-11","endDate":null,"createdBy":"PWEST","dateCreated":"2004-07-26","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Incomplete response/SD","valueDescription":"INCOMPLETE RESPONSE OR STABLE DISESASE","ValueMeaning":{"publicId":"2558961","version":"1","preferredName":"INCOMPLETE RESPONSE OR STABLE DISESASE","longName":"2558961v1.00","preferredDefinition":"Persistence of one or more non-target lesions.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Incomplete Response/Stable Disease","conceptCode":"C150562","definition":"Persistence of one or more non-target lesions.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B35E-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"KUMMEROA","dateModified":"2023-09-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E0258697-04D3-5468-E034-0003BA12F5E7","beginDate":"2002-02-11","endDate":null,"createdBy":"PWEST","dateCreated":"2004-07-26","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Insufficient evaluation to determine response status","valueDescription":"INSUFFICIENT EVALUATION","ValueMeaning":{"publicId":"2558974","version":"1","preferredName":"INSUFFICIENT EVALUATION","longName":"2558974v1.00","preferredDefinition":"Not meeting a quantitative or qualitative measure necessary for a requirement._Systematic, objective appraisal of the significance, effectiveness, and impact of activities or condition according to specified objectives and criteria.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Inadequate","conceptCode":"C69177","definition":"Not meeting a quantitative or qualitative measure necessary for a requirement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Evaluation","conceptCode":"C25214","definition":"Systematic, objective appraisal of the significance, effectiveness, and impact of activities or condition according to specified objectives and criteria.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B36B-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"KUMMEROA","dateModified":"2023-09-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E0258697-04D5-5468-E034-0003BA12F5E7","beginDate":"2002-02-11","endDate":null,"createdBy":"PWEST","dateCreated":"2004-07-26","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"PD","valueDescription":"Progressive Disease","ValueMeaning":{"publicId":"2559908","version":"1","preferredName":"Progressive Disease","longName":"2559908","preferredDefinition":"Cancer that is increasing in scope or severity.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Progressive Disease","conceptCode":"C35571","definition":"A clinical, pathologic, and/or molecular finding indicating that the course of a disease is worsening in terms of extent or severity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B711-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"HARTLEYG","dateModified":"2014-10-10","changeDescription":"Manually Curated for OHSU 10262","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E0258697-04D7-5468-E034-0003BA12F5E7","beginDate":"2002-07-10","endDate":null,"createdBy":"PWEST","dateCreated":"2004-07-26","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"PR","valueDescription":"Partial Response","ValueMeaning":{"publicId":"2559721","version":"1","preferredName":"Partial Response","longName":"2559721","preferredDefinition":"A decrease in the size of a tumor, or in the extent of cancer in the body, in response to treatment.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Partial Response","conceptCode":"C18212","definition":"A decrease in the size of a tumor, or in the extent of cancer in the body, in response to treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B656-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SOKKERL","dateModified":"2023-09-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E0258697-04D9-5468-E034-0003BA12F5E7","beginDate":"2002-07-10","endDate":null,"createdBy":"PWEST","dateCreated":"2004-07-26","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"SD","valueDescription":"Stable Disease","ValueMeaning":{"publicId":"2560100","version":"1","preferredName":"Stable Disease","longName":"2560100","preferredDefinition":"Cancer that is neither decreasing nor increasing in extent or severity.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stable Disease","conceptCode":"C18213","definition":"A disease that is neither decreasing nor increasing in extent or severity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B7D1-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"KUMMEROA","dateModified":"2022-09-13","changeDescription":"Manually curated for OHSU 10262","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E0258697-04DB-5468-E034-0003BA12F5E7","beginDate":"2002-07-10","endDate":null,"createdBy":"PWEST","dateCreated":"2004-07-26","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"NED","valueDescription":"NED","ValueMeaning":{"publicId":"2568728","version":"1","preferredName":"NED","longName":"2568728v1.00","preferredDefinition":"Diagnostic tests fail to detect presence of disease.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"No Evidence of Disease","conceptCode":"C40413","definition":"Diagnostic tests fail to detect presence of disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D985-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-18","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-03-18","modifiedBy":"KUMMEROA","dateModified":"2023-09-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E0258697-04DD-5468-E034-0003BA12F5E7","beginDate":"2004-03-18","endDate":null,"createdBy":"PWEST","dateCreated":"2004-07-26","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Recurrence","valueDescription":"Recurrence","ValueMeaning":{"publicId":"2565643","version":"1","preferredName":"Recurrence","longName":"2565643","preferredDefinition":"To occur again.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Recurrence","conceptCode":"C3352","definition":"Happening again (especially at regular intervals).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-CD78-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-02-20","endDate":null,"createdBy":"CVALMONT","dateCreated":"2003-02-20","modifiedBy":"KUMMEROA","dateModified":"2023-09-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E0263A80-8F38-5465-E034-0003BA12F5E7","beginDate":"2003-02-20","endDate":null,"createdBy":"PWEST","dateCreated":"2004-07-26","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Not evaluated","valueDescription":"Not Evaluated","ValueMeaning":{"publicId":"2570488","version":"1","preferredName":"Not Evaluated","longName":"2570488","preferredDefinition":"The non-affirmative response to a question.: Systematic, objective appraisal of the significance, effectiveness, and impact of activities or condition according to specified objectives and criteria.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"No","conceptCode":"C49487","definition":"The non-affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Evaluation","conceptCode":"C25214","definition":"Systematic, objective appraisal of the significance, effectiveness, and impact of activities or condition according to specified objectives and criteria.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E065-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-06-21","endDate":null,"createdBy":"SBR","dateCreated":"2004-06-21","modifiedBy":"CLOHNES","dateModified":"2022-11-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E0263A80-8F3B-5465-E034-0003BA12F5E7","beginDate":"2002-02-11","endDate":null,"createdBy":"PWEST","dateCreated":"2004-07-26","modifiedBy":"SBREXT","dateModified":"2007-06-22","deletedIndicator":"No"},{"value":"Not reported","valueDescription":"Not Reported","ValueMeaning":{"publicId":"2572231","version":"1","preferredName":"Not Reported","longName":"2572231","preferredDefinition":"Not provided or available.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Reported","conceptCode":"C43234","definition":"Not provided or available.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E734-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-11-16","endDate":null,"createdBy":"MAESKEB","dateCreated":"2004-11-16","modifiedBy":"CLOHNES","dateModified":"2023-11-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"285AB443-8913-74BB-E044-0003BA3F9857","beginDate":"2007-01-31","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-01-31","modifiedBy":"ONEDATA","dateModified":"2007-01-31","deletedIndicator":"No"},{"value":"REGR","valueDescription":"Regression","ValueMeaning":{"publicId":"2631957","version":"1","preferredName":"Regression","longName":"2631957","preferredDefinition":"A decrease in the size of a tumor or in the extent of cancer in the body.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Regression","conceptCode":"C18243","definition":"Return to a former state; a subsidence of the symptoms of a disease process; in cancer, a decrease in the size of a tumor or in the extent of cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2EDE3CEA-3A2C-2970-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-04-24","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-04-24","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2EDE3CEA-3A44-2970-E044-0003BA3F9857","beginDate":"2004-04-20","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-04-24","modifiedBy":"CAMPBELB","dateModified":"2007-04-24","deletedIndicator":"No"},{"value":"MRD","valueDescription":"Minimal Residual Disease","ValueMeaning":{"publicId":"2829698","version":"1","preferredName":"Minimal Residual Disease","longName":"2829698v1.00","preferredDefinition":"Evidence for remaining tumor following primary treatment that is only apparent using highly sensitive techniques.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Measurable Residual Disease","conceptCode":"C3896","definition":"Evidence for remaining tumor following primary treatment that is only apparent using highly sensitive techniques.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"61694C36-35BF-DC55-E040-BB89AD43020E","latestVersionIndicator":"Yes","beginDate":"2009-01-26","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-01-26","modifiedBy":"KUMMEROA","dateModified":"2023-09-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7312B8A2-4204-9F92-E040-BB89AD43741C","beginDate":"2009-09-08","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-09-08","modifiedBy":"ONEDATA","dateModified":"2009-09-08","deletedIndicator":"No"},{"value":"CRu","valueDescription":"Complete response, unconfirmed","ValueMeaning":{"publicId":"3719078","version":"1","preferredName":"Complete response, unconfirmed","longName":"3719078v1.00","preferredDefinition":"An indication that a finding of complete response to treatment has not been confirmed.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Complete Response Unconfirmed","conceptCode":"C165198","definition":"An indication that a finding of complete response to treatment has not been confirmed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D9F50E03-6F10-7266-E040-BB89AD434E6F","latestVersionIndicator":"Yes","beginDate":"2013-04-09","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2013-04-09","modifiedBy":"KUMMEROA","dateModified":"2023-09-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D9F50E03-6F29-7266-E040-BB89AD434E6F","beginDate":"2013-04-09","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2013-04-09","modifiedBy":"ONEDATA","dateModified":"2013-04-09","deletedIndicator":"No"},{"value":"MR","valueDescription":"Minimal response","ValueMeaning":{"publicId":"3263659","version":"1","preferredName":"Minimal response","longName":"3263659v1.00","preferredDefinition":"A finding indicating that there is an improvement in the measures of disease burden, meeting a predetermined threshold, but not meeting partial response criteria.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Minimal Response","conceptCode":"C123598","definition":"A finding indicating that there is an improvement in the measures of disease burden, meeting a predetermined threshold, but not meeting partial response criteria.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB461F5D-3EB3-78CA-E040-BB89AD434E2B","latestVersionIndicator":"Yes","beginDate":"2011-08-24","endDate":null,"createdBy":"SORENSENS","dateCreated":"2011-08-24","modifiedBy":"KUMMEROA","dateModified":"2023-09-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EA725F8F-5B36-2A66-E040-BB89AD437DF7","beginDate":"2013-11-05","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2013-11-05","modifiedBy":"ONEDATA","dateModified":"2013-11-05","deletedIndicator":"No"},{"value":"VGPR","valueDescription":"Very good partial response","ValueMeaning":{"publicId":"3278726","version":"1","preferredName":"Very good partial response","longName":"3278726v1.00","preferredDefinition":"Partial response with additional serum and urine M-protein reduction, but not meeting complete response.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Very Good Partial Response","conceptCode":"C123618","definition":"Partial response with additional serum and urine M-protein reduction, but not meeting complete response.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AD00CE93-1BEC-1C82-E040-BB89AD436E31","latestVersionIndicator":"Yes","beginDate":"2011-09-15","endDate":null,"createdBy":"ZHANGW","dateCreated":"2011-09-15","modifiedBy":"KUMMEROA","dateModified":"2023-09-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EA725F8F-5B4A-2A66-E040-BB89AD437DF7","beginDate":"2013-11-05","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2013-11-05","modifiedBy":"ONEDATA","dateModified":"2013-11-05","deletedIndicator":"No"},{"value":"sCR","valueDescription":"Stringent Complete Response","ValueMeaning":{"publicId":"2955995","version":"1","preferredName":"Stringent Complete Response","longName":"2955995","preferredDefinition":"The confirmed disappearance of all signs of cancer, and absence of molecular or cytogenetic marker of disease, in response to treatment with additional biochemical, immunological and histopathological analyses to verify the CR.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stringent Complete Response","conceptCode":"C123614","definition":"The confirmed disappearance of all signs of cancer, and absence of molecular or cytogenetic marker of disease, in response to treatment with additional biochemical, immunological and histopathological analyses to verify the CR.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"76D78551-E906-AA5D-E040-BB89AD435A4F","latestVersionIndicator":"Yes","beginDate":"2009-10-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2009-10-26","modifiedBy":"MAESKEB","dateModified":"2020-08-12","changeDescription":"Added concept annotation and changed case of Long Name. mc 4/11/17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EA725F8F-5B55-2A66-E040-BB89AD437DF7","beginDate":"2013-11-05","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2013-11-05","modifiedBy":"ONEDATA","dateModified":"2013-11-05","deletedIndicator":"No"},{"value":"PRm-","valueDescription":"PRm-","ValueMeaning":{"publicId":"4512851","version":"1","preferredName":"PRm-","longName":"4512851v1.00","preferredDefinition":"A finding of normality following an examination or investigation looking for the presence of a microorganism, disease, or condition._A syndrome characterized by pain, stiffness, and tenderness of the proximal muscle groups including the shoulder, pelvic girdle and the neck. There is no muscle atrophy and muscle biopsies do not reveal pathologic changes. Additional signs and symptoms include low grade fever, fatigue and depression.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Negative Finding","conceptCode":"C38757","definition":"A finding of normality following an examination or investigation looking for the presence of a microorganism, disease, or condition.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Polymyalgia Rheumatica","conceptCode":"C85018","definition":"A syndrome characterized by pain, stiffness, and tenderness of the proximal muscle groups including the shoulder, pelvic girdle and the neck. There is no muscle atrophy and muscle biopsies do not reveal pathologic changes. Additional signs and symptoms include low grade fever, fatigue and depression.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"04C8393C-10C2-017F-E050-BB89AD435DB7","latestVersionIndicator":"Yes","beginDate":"2014-10-06","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2014-10-06","modifiedBy":"KUMMEROA","dateModified":"2023-09-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"04C8393C-10DB-017F-E050-BB89AD435DB7","beginDate":"2014-10-06","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2014-10-06","modifiedBy":"ONEDATA","dateModified":"2014-10-06","deletedIndicator":"No"},{"value":"PRm+","valueDescription":"PRm+","ValueMeaning":{"publicId":"4512852","version":"1","preferredName":"PRm+","longName":"4512852v1.00","preferredDefinition":"A finding of abnormality following an examination or observation confirming something, such as the presence of a disease, condition, or microorganism._A syndrome characterized by pain, stiffness, and tenderness of the proximal muscle groups including the shoulder, pelvic girdle and the neck. There is no muscle atrophy and muscle biopsies do not reveal pathologic changes. Additional signs and symptoms include low grade fever, fatigue and depression.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Positive Finding","conceptCode":"C38758","definition":"A finding of abnormality following an examination or observation confirming something, such as the presence of a disease, condition, or microorganism.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Polymyalgia Rheumatica","conceptCode":"C85018","definition":"A syndrome characterized by pain, stiffness, and tenderness of the proximal muscle groups including the shoulder, pelvic girdle and the neck. There is no muscle atrophy and muscle biopsies do not reveal pathologic changes. Additional signs and symptoms include low grade fever, fatigue and depression.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"04C8393C-10E5-017F-E050-BB89AD435DB7","latestVersionIndicator":"Yes","beginDate":"2014-10-06","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2014-10-06","modifiedBy":"KUMMEROA","dateModified":"2023-09-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"04C8393C-10FE-017F-E050-BB89AD435DB7","beginDate":"2014-10-06","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2014-10-06","modifiedBy":"ONEDATA","dateModified":"2014-10-06","deletedIndicator":"No"},{"value":"Not applicable","valueDescription":"Not applicable","ValueMeaning":{"publicId":"2581003","version":"1","preferredName":"Not applicable","longName":"2581003v1.00","preferredDefinition":"Determination of a value is not relevant in the current context.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Applicable","conceptCode":"C48660","definition":"Determination of a value is not relevant in the current context.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0978-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-12-31","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-12-31","modifiedBy":"CLOHNES","dateModified":"2023-11-09","changeDescription":null,"administrativeNotes":"2023.3.6 Added Alt VM-COG. ak","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"04C8393C-1108-017F-E050-BB89AD435DB7","beginDate":"2014-10-06","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2014-10-06","modifiedBy":"ONEDATA","dateModified":"2014-10-06","deletedIndicator":"No"},{"value":"Unknown","valueDescription":"Unknown","ValueMeaning":{"publicId":"5682944","version":"1","preferredName":"Unknown","longName":"5682944","preferredDefinition":"Not known, not observed, not recorded, or refused.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"498B0E12-9AE5-79DC-E053-F662850A0B75","latestVersionIndicator":"Yes","beginDate":"2017-02-27","endDate":null,"createdBy":"ALEYR","dateCreated":"2017-02-27","modifiedBy":"GDEEN","dateModified":"2023-12-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"67431CA8-A19A-4F02-E053-F662850A1A7C","beginDate":"2018-03-13","endDate":null,"createdBy":"MORENOC","dateCreated":"2018-03-13","modifiedBy":"ONEDATA","dateModified":"2018-03-13","deletedIndicator":"No"},{"value":"Local enlargement","valueDescription":"Local Enlargement","ValueMeaning":{"publicId":"6334942","version":"1","preferredName":"Local Enlargement","longName":"6334942","preferredDefinition":"Of or belonging to a restricted area or locality.: The act of increasing (something) in size or volume or quantity or scope.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Local","conceptCode":"C67263","definition":"Of or belonging to a restricted area or locality.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Enlargement","conceptCode":"C73432","definition":"The act of increasing (something) in size or volume or quantity or scope.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6E871EC6-0A49-0F10-E053-F662850A2874","latestVersionIndicator":"Yes","beginDate":"2018-06-13","endDate":null,"createdBy":"PATELV","dateCreated":"2018-06-13","modifiedBy":"ONEDATA","dateModified":"2018-06-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6E871EC6-0A62-0F10-E053-F662850A2874","beginDate":"2018-06-13","endDate":null,"createdBy":"PATELV","dateCreated":"2018-06-13","modifiedBy":"ONEDATA","dateModified":"2018-06-13","deletedIndicator":"No"},{"value":"Local failure","valueDescription":"Local Failure","ValueMeaning":{"publicId":"6334944","version":"1","preferredName":"Local Failure","longName":"6334944","preferredDefinition":"Of or belonging to a restricted area or locality.: A lack of occurrence or performance.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Local","conceptCode":"C67263","definition":"Of or belonging to a restricted area or locality.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Failure","conceptCode":"C25745","definition":"A lack of occurrence or performance.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6E871EC6-0AA8-0F10-E053-F662850A2874","latestVersionIndicator":"Yes","beginDate":"2018-06-13","endDate":null,"createdBy":"PATELV","dateCreated":"2018-06-13","modifiedBy":"KUMMEROA","dateModified":"2023-07-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6E871EC6-0AC1-0F10-E053-F662850A2874","beginDate":"2018-06-13","endDate":null,"createdBy":"PATELV","dateCreated":"2018-06-13","modifiedBy":"ONEDATA","dateModified":"2018-06-13","deletedIndicator":"No"},{"value":"MRD-","valueDescription":"Minimal Residual Disease Negativity","ValueMeaning":{"publicId":"5654916","version":"1","preferredName":"Minimal Residual Disease Negativity","longName":"5654916","preferredDefinition":"Absence of residual disease based on laboratory techniques.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Measurable Residual Disease Negativity","conceptCode":"C124428","definition":"Absence of residual disease based on laboratory techniques.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"47E1D321-5203-5A79-E053-F662850A5552","latestVersionIndicator":"Yes","beginDate":"2017-02-06","endDate":null,"createdBy":"COLBERTM","dateCreated":"2017-02-06","modifiedBy":"ONEDATA_WA","dateModified":"2023-07-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6F289ED6-E810-5976-E053-F662850A2391","beginDate":"2018-06-21","endDate":null,"createdBy":"MORENOC","dateCreated":"2018-06-21","modifiedBy":"ONEDATA","dateModified":"2018-06-21","deletedIndicator":"No"},{"value":"Refractory/PR/Progressive Disease","valueDescription":"Refractory Partial Remission Progressive Disease","ValueMeaning":{"publicId":"6338168","version":"1","preferredName":"Refractory Partial Remission Progressive Disease","longName":"6338168","preferredDefinition":"Not responding to treatment.: A finding indicating that there is a decrease in the size and the extent of tissue involvement by a malignant tumor in a patient.: A disease process that is increasing in scope or severity.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Refractory","conceptCode":"C38014","definition":"Not responding to treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Partial Remission","conceptCode":"C18058","definition":"A finding indicating that there is a decrease in the size and the extent of tissue involvement by a malignant tumor in a patient.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Progressive Disease","conceptCode":"C35571","definition":"A clinical, pathologic, and/or molecular finding indicating that the course of a disease is worsening in terms of extent or severity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6F27BF81-E41C-7387-E053-F662850A6C39","latestVersionIndicator":"Yes","beginDate":"2018-06-21","endDate":null,"createdBy":"MORENOC","dateCreated":"2018-06-21","modifiedBy":"ONEDATA","dateModified":"2018-06-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6F289ED6-E825-5976-E053-F662850A2391","beginDate":"2018-06-21","endDate":null,"createdBy":"MORENOC","dateCreated":"2018-06-21","modifiedBy":"ONEDATA","dateModified":"2018-06-21","deletedIndicator":"No"},{"value":"Preliminary PD","valueDescription":"Initial Progressive Disease","ValueMeaning":{"publicId":"6617863","version":"1","preferredName":"Initial Progressive Disease","longName":"6617863v1.00","preferredDefinition":"Preceding all others in time or space or degree._A clinical, pathologic, and/or molecular finding indicating that the course of a disease is worsening in terms of extent or severity.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"First","conceptCode":"C25509","definition":"Preceding all others in time or space or degree.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Progressive Disease","conceptCode":"C35571","definition":"A clinical, pathologic, and/or molecular finding indicating that the course of a disease is worsening in terms of extent or severity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7FFB2548-0F77-4100-E053-F662850A6A02","latestVersionIndicator":"Yes","beginDate":"2019-01-22","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-01-22","modifiedBy":"KUMMEROA","dateModified":"2023-09-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7FFB2548-0F90-4100-E053-F662850A6A02","beginDate":"2019-01-22","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-01-22","modifiedBy":"ONEDATA","dateModified":"2019-01-22","deletedIndicator":"No"},{"value":"Confirmed PD","valueDescription":"Progressive Disease, Confirmed","ValueMeaning":{"publicId":"5895898","version":"1","preferredName":"Progressive Disease, Confirmed","longName":"5895898","preferredDefinition":"Having been established or verified.: A disease process that is increasing in scope or severity.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Confirmation","conceptCode":"C25458","definition":"Having been established or verified.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Progressive Disease","conceptCode":"C35571","definition":"A clinical, pathologic, and/or molecular finding indicating that the course of a disease is worsening in terms of extent or severity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"53BAF5DA-7116-75C8-E053-F662850AED93","latestVersionIndicator":"Yes","beginDate":"2017-07-07","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-07-07","modifiedBy":"HARTLEYG","dateModified":"2018-04-24","changeDescription":"User curated long name to support DCI, Modified RANO, ghd, 04.24.18","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7FFB2548-0FA4-4100-E053-F662850A6A02","beginDate":"2019-01-22","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-01-22","modifiedBy":"ONEDATA","dateModified":"2019-01-22","deletedIndicator":"No"},{"value":"Non-CR and Non-PD","valueDescription":"Non Complete Response/Non Progressive Disease","ValueMeaning":{"publicId":"5946383","version":"1","preferredName":"Non Complete Response/Non Progressive Disease","longName":"5946383v1.00","preferredDefinition":"Persistence of one or more non-target lesion(s) and/or maintenance of tumor marker levels above the normal limits. (RECIST)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Non Complete Response/Non Progressive Disease","conceptCode":"C96700","definition":"Persistence of one or more non-target lesion(s) and/or maintenance of tumor marker levels above the normal limits. (RECIST)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"58007ED1-215D-70C3-E053-F662850A7199","latestVersionIndicator":"Yes","beginDate":"2017-08-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-08-30","modifiedBy":"MMADDINENI","dateModified":"2022-08-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"85B4008F-BF5F-4542-E053-F662850AE56C","beginDate":"2019-04-04","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-04-04","modifiedBy":"ONEDATA","dateModified":"2019-04-04","deletedIndicator":"No"},{"value":"Non-CR, Non-PD and Clinically Stable iUPD","valueDescription":"Non-CR, Non-PD and Clinically Stable iUPD","ValueMeaning":{"publicId":"7550020","version":"1","preferredName":"Non-CR, Non-PD and Clinically Stable iUPD","longName":"7550020v1.00","preferredDefinition":"Persistence of one or more non-target lesion(s) and/or maintenance of tumor marker levels above the normal limits. (RECIST)_An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence._Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity._Subject to little fluctuation; showing little if any change._Apparent radiographic progression which requires confirmation, per criteria, with additional imaging.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Non Complete Response/Non Progressive Disease","conceptCode":"C96700","definition":"Persistence of one or more non-target lesion(s) and/or maintenance of tumor marker levels above the normal limits. (RECIST)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"And","conceptCode":"C37912","definition":"An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Clinical","conceptCode":"C25398","definition":"Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Stable","conceptCode":"C30103","definition":"Subject to little fluctuation; showing little if any change.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"iRECIST Unconfirmed Progressive Disease","conceptCode":"C142360","definition":"Apparent radiographic progression which requires confirmation, per criteria, with additional imaging.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B8F23E3B-6A2F-254E-E053-4EBD850A33D7","latestVersionIndicator":"Yes","beginDate":"2021-01-15","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2021-01-15","modifiedBy":"KUMMEROA","dateModified":"2023-09-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B8F23E3B-6A48-254E-E053-4EBD850A33D7","beginDate":"2021-01-15","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2021-01-15","modifiedBy":"ONEDATA","dateModified":"2021-01-15","deletedIndicator":"No"},{"value":"iCPD or iUPD with clinical progression","valueDescription":"iCPD or iUPD with clinical progression","ValueMeaning":{"publicId":"7550021","version":"1","preferredName":"iCPD or iUPD with clinical progression","longName":"7550021v1.00","preferredDefinition":"Radiographic progression which has been confirmed by additional imaging showing worsening of initial progression._An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise._Apparent radiographic progression which requires confirmation, per criteria, with additional imaging._An evaluation of the clinical response of the disease to the therapy._A process that manifests as the worsening of a disease over time.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"iRECIST Confirmed Progressive Disease","conceptCode":"C142356","definition":"Radiographic progression which has been confirmed by additional imaging showing worsening of initial progression.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Or","conceptCode":"C37998","definition":"An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"iRECIST Unconfirmed Progressive Disease","conceptCode":"C142360","definition":"Apparent radiographic progression which requires confirmation, per criteria, with additional imaging.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Clinical Response","conceptCode":"C123619","definition":"An evaluation of the clinical response of the disease to the therapy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Disease Progression","conceptCode":"C17747","definition":"A process that manifests as the worsening of a disease over time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B8F23E3B-6A52-254E-E053-4EBD850A33D7","latestVersionIndicator":"Yes","beginDate":"2021-01-15","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2021-01-15","modifiedBy":"KUMMEROA","dateModified":"2023-09-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B8F23E3B-6A6B-254E-E053-4EBD850A33D7","beginDate":"2021-01-15","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2021-01-15","modifiedBy":"ONEDATA","dateModified":"2021-01-15","deletedIndicator":"No"},{"value":"Not present","valueDescription":null,"ValueMeaning":{"publicId":"3204360","version":"1","preferredName":"Absent","longName":"3204360","preferredDefinition":"Not existing in a specified place at a specified time.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Absent","conceptCode":"C48190","definition":"Not existing in a specified place at a specified time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9E9F26F2-9C11-947B-E040-BB89AD434D7C","latestVersionIndicator":"Yes","beginDate":"2011-03-16","endDate":null,"createdBy":"LUY","dateCreated":"2011-03-16","modifiedBy":"CLOHNES","dateModified":"2023-11-14","changeDescription":"Concept annotation added for UPitt/TCGA.  Ylu, 01/30/2015.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E895EB69-ACFF-0898-E053-731AD00A13CE","beginDate":"2022-09-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-09-13","modifiedBy":"KUMMEROA","dateModified":"2022-09-13","deletedIndicator":"No"},{"value":"NA based on baseline assessment","valueDescription":null,"ValueMeaning":{"publicId":"11253497","version":"1","preferredName":"Baseline Assessment Basis Not Applicable","longName":"11253497v1.00","preferredDefinition":"Examination of an individual prior to an event or intervention._The fundamental assumptions underlying an explanation or a relation that provide the foundation for something._Determination of a value is not relevant in the current context.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Baseline Assessment","conceptCode":"C142400","definition":"Examination of an individual prior to an event or intervention.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Basis","conceptCode":"C25430","definition":"The fundamental assumptions underlying an explanation or a relation that provide the foundation for something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Not Applicable","conceptCode":"C48660","definition":"Determination of a value is not relevant in the current context.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E8CB9B16-DB25-1EA5-E053-731AD00A3BCE","latestVersionIndicator":"Yes","beginDate":"2022-09-16","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-09-16","modifiedBy":"MMADDINENI","dateModified":"2024-02-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E8CBB6F6-5798-2168-E053-731AD00A6BE3","beginDate":"2022-09-16","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-09-16","modifiedBy":"KUMMEROA","dateModified":"2022-09-16","deletedIndicator":"No"},{"value":"Preliminary CR","valueDescription":null,"ValueMeaning":{"publicId":"2770751","version":"1","preferredName":"Complete Response, Preliminary","longName":"2770751","preferredDefinition":"Preceding all others in time or space or degree.: The disappearance of all signs of cancer in response to treatment.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"First","conceptCode":"C25509","definition":"Preceding all others in time or space or degree.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Complete Remission","conceptCode":"C4870","definition":"The disappearance of all signs of cancer in response to treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"53E0F58A-823C-509B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"COOPERM","dateCreated":"2008-08-07","modifiedBy":"KUMMEROA","dateModified":"2023-09-07","changeDescription":"User curated long name to support DCI, Modified RANO, ghd, 04.24.18","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"04C8B41B-352D-5731-E063-731AD00AEFC6","beginDate":"2023-09-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-09-07","modifiedBy":"KUMMEROA","dateModified":"2023-09-07","deletedIndicator":"No"},{"value":"Preliminary PR","valueDescription":null,"ValueMeaning":{"publicId":"2688949","version":"1","preferredName":"Partial Response, Preliminary","longName":"2688949","preferredDefinition":"Preceding all others in time or space or degree.: A finding indicating that there is a decrease in the size and the extent of tissue involvement by a malignant tumor in a patient.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"First","conceptCode":"C25509","definition":"Preceding all others in time or space or degree.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Partial Remission","conceptCode":"C18058","definition":"A finding indicating that there is a decrease in the size and the extent of tissue involvement by a malignant tumor in a patient.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3C4BE624-D345-0D2B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-10-12","endDate":null,"createdBy":"ALEYR","dateCreated":"2007-10-12","modifiedBy":"SOKKERL","dateModified":"2023-09-07","changeDescription":"User curated long name to support DCI, Modified RANO, ghd, 04.24.18","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"04C900DE-D9E1-639A-E063-731AD00A75EA","beginDate":"2023-09-07","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-09-07","modifiedBy":"SOKKERL","dateModified":"2023-09-07","deletedIndicator":"No"},{"value":"Pseudoresponse","valueDescription":null,"ValueMeaning":{"publicId":"5608378","version":"1","preferredName":"Pseudoresponse","longName":"5608378","preferredDefinition":"A marked decrease in contrast enhancement that is not due to actual tumor shrinkage, but that may be due to anti-angiogenic therapy or an increase in steroid dosage.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pseudoresponse","conceptCode":"C131142","definition":"A marked decrease in contrast enhancement that is not due to actual tumor shrinkage, but that may be due to anti-angiogenic therapy or an increase in steroid dosage.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"441B5856-09BA-6675-E053-F662850A5A59","latestVersionIndicator":"Yes","beginDate":"2016-12-20","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-12-20","modifiedBy":"SOKKERL","dateModified":"2023-09-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"04C94C96-2AEB-7263-E063-731AD00A88CD","beginDate":"2023-09-07","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-09-07","modifiedBy":"SOKKERL","dateModified":"2023-09-07","deletedIndicator":"No"},{"value":"Pseudoprogression","valueDescription":null,"ValueMeaning":{"publicId":"3294017","version":"1","preferredName":"Pseudoprogression","longName":"3294017","preferredDefinition":"A radiologic finding observed during magnetic resonance imaging of brain glioblastoma, following concurrent radiotherapy and temozolomide treatment or vaccine therapy. It refers to the false positive finding of progression and enhancement of the lesion. It is considered a treatment effect due to tumor cell necrosis and subsequent edema formation and increased vascular permeability.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pseudoprogression","conceptCode":"C98298","definition":"A radiologic finding observed during magnetic resonance imaging of brain glioblastoma, following concurrent radiotherapy and temozolomide treatment or vaccine therapy. It refers to the false positive finding of progression and enhancement of the lesion. It is considered a treatment effect due to tumor cell necrosis and subsequent edema formation and increased vascular permeability.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AF34AFA7-30AC-6D2E-E040-BB89AD4364C0","latestVersionIndicator":"Yes","beginDate":"2011-10-13","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-10-13","modifiedBy":"SOKKERL","dateModified":"2023-09-07","changeDescription":"Added concept annotation. mc 4/11/17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"04C94C96-2AEC-7263-E063-731AD00A88CD","beginDate":"2023-09-07","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-09-07","modifiedBy":"SOKKERL","dateModified":"2023-09-07","deletedIndicator":"No"},{"value":"Stable disease (SD) < 24 weeks","valueDescription":null,"ValueMeaning":{"publicId":"4281795","version":"1","preferredName":"Stable disease (SD) < 24 weeks","longName":"4281795v1.00","preferredDefinition":"A statement about the relative size or order of two objects specifying that an object of interest is smaller than another object in quantity or measure or value or status._A natural number greater than twenty-three and less than twenty-five and the quantity that it denotes._Any period of seven consecutive days._A disease that is neither decreasing nor increasing in extent or severity.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Less Than","conceptCode":"C61585","definition":"A statement about the relative size or order of two objects specifying that an object of interest is smaller than another object in quantity or measure or value or status.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Twenty Four","conceptCode":"C113753","definition":"A natural number greater than twenty-three and less than twenty-five and the quantity that it denotes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Week","conceptCode":"C29844","definition":"Any period of seven consecutive days.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Stable Disease","conceptCode":"C18213","definition":"A disease that is neither decreasing nor increasing in extent or severity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F81A96AE-7521-71FA-E040-BB89AD435FE8","latestVersionIndicator":"Yes","beginDate":"2014-04-28","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2014-04-28","modifiedBy":"KUMMEROA","dateModified":"2023-09-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"054264FC-286F-27FE-E063-731AD00A1E0B","beginDate":"2023-09-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-09-13","modifiedBy":"KUMMEROA","dateModified":"2023-09-13","deletedIndicator":"No"},{"value":"Stable disease (SD) > or = 24 weeks","valueDescription":null,"ValueMeaning":{"publicId":"4281796","version":"1","preferredName":"Stable disease (SD) > or = 24 weeks","longName":"4281796v1.00","preferredDefinition":"A statement about the relative size or order of two objects specifying that either both objects are the same in quantity or measure or value or status or that the object of interest exceeds the other object in one of these ways._A natural number greater than twenty-three and less than twenty-five and the quantity that it denotes._Any period of seven consecutive days._A disease that is neither decreasing nor increasing in extent or severity.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Greater Than or Equal To","conceptCode":"C61583","definition":"A statement about the relative size or order of two objects specifying that either both objects are the same in quantity or measure or value or status or that the object of interest exceeds the other object in one of these ways.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Twenty Four","conceptCode":"C113753","definition":"A natural number greater than twenty-three and less than twenty-five and the quantity that it denotes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Week","conceptCode":"C29844","definition":"Any period of seven consecutive days.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Stable Disease","conceptCode":"C18213","definition":"A disease that is neither decreasing nor increasing in extent or severity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F81A96AE-7544-71FA-E040-BB89AD435FE8","latestVersionIndicator":"Yes","beginDate":"2014-04-28","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2014-04-28","modifiedBy":"KUMMEROA","dateModified":"2023-09-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"054264FC-2870-27FE-E063-731AD00A1E0B","beginDate":"2023-09-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-09-13","modifiedBy":"KUMMEROA","dateModified":"2023-09-13","deletedIndicator":"No"},{"value":"NE|Not evaluable","valueDescription":null,"ValueMeaning":{"publicId":"2581117","version":"1","preferredName":"Not Evaluable (NE)","longName":"2581117","preferredDefinition":"Unable to be evaluated.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unevaluable","conceptCode":"C62222","definition":"Unable to be evaluated.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-09EA-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-10-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-10-02","modifiedBy":"COOPERM","dateModified":"2018-03-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"054264FC-2871-27FE-E063-731AD00A1E0B","beginDate":"2023-09-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-09-13","modifiedBy":"KUMMEROA","dateModified":"2023-09-13","deletedIndicator":"No"},{"value":"Non-measurable disease at baseline","valueDescription":null,"ValueMeaning":{"publicId":"2771504","version":"1","preferredName":"Non-measurable disease at baseline","longName":"2771504v1.00","preferredDefinition":"A starting point to which things may be compared._An operation in which a term denies or inverts the meaning of another term or construction._A finding indicating that a subject has one or more measurable pathological lesions.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Baseline","conceptCode":"C25213","definition":"A starting point to which things may be compared.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Negation","conceptCode":"C25594","definition":"An operation in which a term denies or inverts the meaning of another term or construction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Measurable Disease","conceptCode":"C8507","definition":"A finding indicating that a subject has one or more measurable pathological lesions.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"53F7954D-03AD-6FC6-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-08-08","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-08-08","modifiedBy":"KUMMEROA","dateModified":"2023-09-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"05427B0C-02A5-2C45-E063-731AD00A0D3E","beginDate":"2023-09-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-09-13","modifiedBy":"KUMMEROA","dateModified":"2023-09-13","deletedIndicator":"No"},{"value":"cCR","valueDescription":null,"ValueMeaning":{"publicId":"5838504","version":"1","preferredName":"Clinical Complete Response","longName":"5838504","preferredDefinition":"The disappearance of all signs of cancer based on physical exam, such as palpation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical Complete Response","conceptCode":"C123574","definition":"The disappearance of all signs of cancer based on physical exam, such as palpation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"506DC049-356A-7059-E053-F662850A6D2C","latestVersionIndicator":"Yes","beginDate":"2017-05-26","endDate":null,"createdBy":"SOKKERL","dateCreated":"2017-05-26","modifiedBy":"CLOHNES","dateModified":"2023-11-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"05427B0C-02A6-2C45-E063-731AD00A0D3E","beginDate":"2023-09-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-09-13","modifiedBy":"KUMMEROA","dateModified":"2023-09-13","deletedIndicator":"No"},{"value":"Possible pseudoprogression","valueDescription":null,"ValueMeaning":{"publicId":"4735772","version":"1","preferredName":"Possible Pseudoprogression","longName":"4735772","preferredDefinition":"Capable of happening or occurring.: A radiologic finding observed during magnetic resonance imaging of brain glioblastoma, following concurrent radiotherapy and temozolomide treatment. It refers to the false positive finding of progression and enhancement of the lesion. It is considered a treatment effect due to tumor cell necrosis and subsequent edema formation and increased vascular permeability.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Possible","conceptCode":"C82490","definition":"Capable of happening or occurring.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Pseudoprogression","conceptCode":"C98298","definition":"A radiologic finding observed during magnetic resonance imaging of brain glioblastoma, following concurrent radiotherapy and temozolomide treatment or vaccine therapy. It refers to the false positive finding of progression and enhancement of the lesion. It is considered a treatment effect due to tumor cell necrosis and subsequent edema formation and increased vascular permeability.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"108FFF1F-1F4F-1C1B-E050-BB89AD433664","latestVersionIndicator":"Yes","beginDate":"2015-03-05","endDate":null,"createdBy":"PATELV","dateCreated":"2015-03-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"05436C83-6063-57E2-E063-731AD00ABA02","beginDate":"2023-09-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-09-13","modifiedBy":"KUMMEROA","dateModified":"2023-09-13","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008550","version":"1","preferredName":"Disease Response","preferredDefinition":"the response criteria (includes RECIST and others) and associated documentation of disease.","longName":"DZ_RESP","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22C0651-216B-5273-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234813","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F90E-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E0258697-04B8-5468-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-07-26","endDate":null,"createdBy":"PWEST","dateCreated":"2004-07-26","modifiedBy":"KUMMEROA","dateModified":"2023-09-13","changeDescription":"request for new values from protocol","administrativeNotes":"2023.9.13 Added PVs from v3 VD. ak 2022.9.16 PV added per ticket request CADSR0001520. ak","unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"4631580","version":"1","longName":"Exceptional Responder CDEs","context":"CTEP","ClassificationSchemeItems":[{"publicId":"4631582","version":"1","longName":"Exceptional Responder CDEs","context":"CTEP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Enter the Imaging Response Ty","type":"Preferred Question Text","description":"Enter the Imaging Response Type as determined by the NCI Imaging Reviewer","url":null,"context":"CTEP"}],"origin":"CTEP:Cancer Therapy Evaluation Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1DC39289-6EA4-ED35-E050-BB89AD432AB1","latestVersionIndicator":"Yes","beginDate":"2015-08-20","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-08-20","modifiedBy":"CAMPBELB","dateModified":"2017-10-04","changeDescription":"Cleanup; Cleanup; ER_CTEP_08.19.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}